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Abstract
HIV retinopathy is the most common non-infectious complication in the eyes of HIV-positive individuals. Oncotic
lesions in the retinal nerve fiber layer, referred to as cotton wool spots (CWS), and intraretinal (IR) hemorrhages are
frequently observed but are not unique to this pathology. HIV-positive patients have impaired color vision and
contrast sensitivity, which worsens with age. Evidence of inner–retinal lesions and damage have been documented
ophthalmoscopically, however their long term structural effect has not been investigated. It has been hypothesized
that they may be partially responsible for loss of visual function and visual field. In this study we utilized clinical data,
retinal imaging and transcriptomics approaches to comprehensively interrogate non-infectious HIV retinopathy. The
methods employed encompassed clinical examinations, fundus photography, indirect ophthalmoscopy, Farmsworth-
Munsell 100 hue discrimination testing and Illumina BeadChip analyses. Here we show that changes in the outer
retina, specifically in the retinal pigment epithelium (RPE) and photoreceptor outer segments (POS) contribute to
vision changes in non-infectious HIV retinopathy. We find that in HIV-positive retinae there is an induction of
rhodopsin and other transcripts (including PDE6A, PDE6B, PDE6G, CNGA1, CNGB1, CRX, NRL) involved in visual
transduction, as well as structural components of the rod photoreceptors (ABCA4 and ROM1). This is consistent with
an increased rate of renewal of rod outer segments induced via increased phagocytosis by HIV-infected RPE
previously reported in culture. Cone-specific transcripts (OPN1SW, OPN1LW, PDE6C, PDE6H and GRK7) are
uniformly downregulated in HIV positive retina, likely due to a partial loss of cone photoreceptors. Active cotton wool
spots and intraretinal hemorrhages (IRH) may not affect photoreceptors directly and the interaction of photoreceptors
with the aging RPE may be the key to the progressive vision changes in HIV-positive patients.
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Introduction
Human immunodeficiency virus (HIV) remains a major public
health problem in the United States with 56,000 new HIV
infections per year [1]. The current prevalence of HIV infection
in the United States is estimated to be over one million with a
disproportionate distribution among minorities, and a
reemerging HIV/AIDS epidemic in gay men [2-4]. Worldwide
the HIV pandemic continues with 33 million infected individuals
and an annual infection rate of 2.7 million with 2 million deaths.
Of those infected less than half of those who urgently needed
antiretroviral therapy (ART) to prevent serious illness or death
were actually receiving it [5]. The increased life expectancy of
human immunodeficiency virus (HIV) positive patients has led
to evidence of complications not directly related to opportunistic
infections [6].
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The human retina, an extension of the central nervous
system, is composed of five major neuronal types and one glial
cell type originating from the same pool of progenitor cells. HIV
retinopathy with vision abnormalities is the most common non-
infectious complication in non-immunocompromised HIV-
positive individuals [7]. It is an ischemic retinopathy. Oncotic
lesions in the retinal nerve fiber layer, also commonly referred
to as cotton wool spots (CWS), and intraretinal (IR)
hemorrhages are commonly observed but are not unique to
this pathology [8-13]. Cotton wool spots manifest as fluffy white
patches on the retina and represent an abnormal finding upon
funduscopic examination of the retina. CWS result from nerve
fiber damage and accumulation of axoplasmic material within
the nerve fiber layer [14]. They occur in approximately 50-60%
of patients with advanced HIV disease and are the earliest and
most consistent finding in HIV retinopathy [15].
Evidence of inner–retinal lesions and damage has been
documented ophthalmoscopically; however their long-term
structural effect has not been investigated. It has been
hypothesized that they may be partially responsible for loss of
visual function and visual field [16-18]. A limited number of
human studies have been performed with animal models
providing the bulk of our knowledge on retinal gene expression
to date. Previous molecular studies of HIV retinopathy have
been confined to a selected group of molecules or genes and
have not provided a systems-level view [19].
In this report we combine clinical data, retinal imaging and
transcriptomics data on non-infectious HIV retinopathy. Recent
advances in retinal imaging provide comprehensive in vivo
histology allowing detection of prior retinal insults from HIV
disease on a scale that was not possible a few years ago.
Furthermore we investigate using systems-level analysis retinal
tissue in autopsy eyes obtained from HIV-positive donors with
either no visible clinical pathology on gross examination or
intraretinal hemorrhages characteristic of HIV retinopathy. We
demonstrate long-term structural and functional modifications
of the retina caused by HIV retinopathy in the absence of
infection or clinically apparent lesions.
Results and Discussion
CWS, after resolution leave behind permanent damage
to the inner retinal layer
We investigated cotton wool spots, and observed that after
resolution permanent damage remained to the inner retinal
layer (Figure 1 A, B). A total of 27 CWS lesions from 14 eyes of
11 HIV-positive male patients were imaged in vivo 2 to 18
years after the active lesion was resolved. The mean time
between the documentation of the active CWS and the SLO/
spectral OCT scan was 10.4 years. The median age of the
patients at the time of the active retinal CWS was 37 years
(range 30 to 46). All patients had CD4 T-cell counts determined
within 3 months of the lesions’ appearance and were below
100x106/L. Analysis of each retinal layer thickness showed that
years after the resolution of a CWS there was a statistically
significant thinning of the inner and middle retinal layers of the
retina: the retinal nerve fiber layer (NFL), ganglion cell layer
(GCL), inner nuclear layer (INL) and outer plexiform layer
(OPL) (p < 0.001) while the outermost inner-retinal layer, the
outer nuclear layer (ONL), was thickened by 17 percent (Figure
1C) (p < 0.001). The thickness of the ONL corresponded to an
expansion of tissue towards the vitreous as a result of the loss
of inner-retinal layers. The greatest tissue loss of 39% was
seen in GCL, followed by the INL and OPL with 22% and 21%
tissue loss respectively. There was no difference in outer
retinal thickness in the center of the fovea between HIV-
positive and HIV-negative human eyes (p = 0.18).
Resolved CWS cause a permanent reduction in local
retinal sensitivity
Analysis of resolved retinal CWS by microperimetry revealed
a permanent reduction in local retinal sensitivity consistent with
interruption of signal transmission from the posterior pole
photoreceptors beneath these CWS to the brain. The mean
microperimetric retinal sensitivity in long-term resolved CWS
was (11.17 ± 4.31 s.d.) dB. The mean sensitivity of the
surrounding retina controls was (14.06 ± 3.17 s.d.) dB (p =
0.02). When a single point of lowest sensitivity was compared
to the control retina the difference was more statistically
significant (p < 0.00001). This demonstrates that in addition to
the permanent anatomical changes observed after resolution of
CWS, a persistent functional deficit remained in those same
areas (Figure 1C).
Color vision is reduced in HIV-positive individuals
We demonstrated impaired visual function in our patient
cohort using psychophysical tests. The Farnsworth-Munsell
100 hue test (Figure 1D) uncovered a reduction in color vision
amongst HIV-positive patients with significant differences
observed between patient groups stratified by CD4 count. The
error scores of the control group are lower than those of the
patient groups. The loss of color vision between groups was
analyzed by two-way ANOVA and the difference between
groups was found to be significant (F2,10370 = 72.9; p <
0.0001). There was also a significant main effect of
Farnsworth-Munsell item number (F84,10370 = 10.4; p <
0.0001), meaning that error scores are significantly higher for
some items than others. However, this is not group-specific:
There is no significant interaction between group and
Farnsworth Munsell item number (F168,10370 = 0.52; p ~ 1).
The color vision deficit is general and not confined to a specific
axis; therefore it is not due to loss or selective damage to one
of the three color pathways within the retina. This finding points
to a general decrease in retinal function.
An example of the CWS microperimetric abnormality
demonstrating long term-damage
An example of this microperimetric abnormality is presented
in Figure 2. The microperimetry examination is overlaid on the
color fundus photograph at the area where the cotton wool spot
was previously (left panel). In the example shown, an
intraretinal hemorrhage is present superotemporal to the
macula and a CWS is inferior to the optic nerve.
An enlarged image of microperimetry overlay is presented in
the middle panel. Sensitivity values in dB are given,
highlighting the decreased sensitivity over the area of previous
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cotton wool spot. This demonstrates the long-term damage that
occurs. A color photograph of the retina of the same eye with a
dot hemorrhage superotemporal to the macula and fading
cotton wool spot is presented in the right panel.
Molecular changes in HIV positive retinae revealed
altered visual perception
To understand the molecular changes in these retinae, we
sampled retinal tissue in HIV positive and negative patients and
included areas affected by macroscopically visible retinopathy.
For transcriptome analysis we extracted RNA from 27 posterior
pole punches; 7 samples from 7 HIV-negative autopsy donors
and 20 from 14 HIV-positive donors. The latter group consisted
of 4 CWS, 6 IR hemorrhages, and 10 samples from
ophthalmologically normal areas of the posterior pole. In the
microarray comparison of lesion-free HIV-positive retinae with
HIV-negative retinae we noted that out of 18,429 detected
probes, 2004 were differentially regulated at a false discovery
rate (FDR) level of 0.01, and 4,541 probes at a FDR level of
0.05. Every gene specifically mentioned in this comparison is
significant at FDR < 0.05 unless otherwise stated. The
biological process most significantly represented was visual
perception (adjusted p-value < 10-12), (Figure S1). This
process is presented in Figure 3 as a heat map to view
differential transcript expression and in Figure 4 as a systems
view network of interacting genes and gene products. Since
retina is a heterogeneous tissue with at least five distinct
neuronal and epithelial cell types, expression data is a
superposition of signals from the constituent cell types. We
focus on unique cellular markers, which allow us to figuratively
peel the layers and glean individual components.
Figure 1.  Oncotic lesions (CWS) in the retinal nerve fiber layer were investigated.  After resolution permanent damage
remained to the inner retinal layer.
A: Color photograph of the retina of an HIV-positive patient with non-infectious retinopathy. Cotton wool spots (arrow) are present
along the retinal blood vessels.
B: Infrared image of the same retina 18 years after resolution of the cotton wool spot with the arrow pointing to its previous location.
The green line represents high-resolution spectral-domain optical coherence tomography (SD-OCT) sectioning through the ischemic
spot co-localizing it to an adjacent B-scan.
C: Adjacent B-scan showing all retinal layers. The hyper-reflective layer on the top is the nerve fiber layer, original location of the
cotton wool spot, which shows thinning. There is a compensatory shift of outer retinal layers including the outer nuclear layer
towards the inner retina (arrowhead).
D: Farnsworth-Munsell diagram showing averaged data for all three groups of eyes. Each group - the group with high CD4, the
group with low CD4, and the control group – was significantly different from every other group (p < 0.0001 in each comparison).
doi: 10.1371/journal.pone.0074712.g001
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The salient feature of this comparison is upregulation of
rhodopsin RHO in HIV-positive retinae (fold change f = 4.4),
rod-specific phosphodiesterase-6 phototransduction enzyme
(subunits PDE6A, PDE6B and PDE6G, f = 5.2, 2.2 and 3.8,
respectively), and phototransduction enzyme CNG4 (subunits
CNGA1 and CNGB1, f = 4.0 and 3.9, respectively) (Figures 3
and 4). The key photoreceptor-specific transcription factor CRX
(f = 1.6) and its partner NRL (f = 3.1) were also upregulated. It
should be noted however that expression of CRX has been
found additionally in RPE [20]. Retinitis pigmentosa 1 (RP1),
which encodes an enzyme involved in rod outer segment
morphogenesis, was also upregulated (f = 2.3). Transcripts of
photoreceptor-specific structural proteins, rim protein ABCA4
and retinal outer segment membrane protein ROM1, which is
essential for disk morphogenesis, were similarly upregulated (f
= 1.6 and 2.8, respectively). Crystallins CRYAA and CRYBB2,
which, in retina, are involved in photoreceptor outer membrane
renewal [21], were both upregulated (f = 1.3, FDR < 0.2, and f
= 1.8, respectively). Retinaldehyde-binding protein 1 (RLBP1),
which is responsible for regeneration and de novo synthesis of
retinoids that cycle between the photoreceptors and RPE was
also upregulated (f = 2.0).
Collectively, upregulation of all rod OS markers, including
structural components, is consistent with an increased (~2-4-
fold) growth rate of rod OS. As the control and HIV donor
groups were not perfectly age-matched (controls were older by
an average of 21 years), the upregulation of RHO and other
rod-specific genes could in principle be explained by a 2-4-fold
loss of rods among the older control donors. However, ample
evidence exists to the contrary: the total amount of RHO in the
eye remains constant between infancy and up to 94 years of
age [22]. In addition, no histological evidence exists for such a
dramatic rod loss in a normally ageing geriatric population.
Homeostasis demands that the faster growth of POS indicated
by the transcriptomics data is matched by an increase in the
rate of phagocytosis of POS by RPE. This conclusion is in
quantitative agreement with Canki et al. [18], who observed
that in culture, exposure to HIV-1 caused a two- to four-fold
increase in the binding and uptake of isolated rod OS by RPE
cells. Increased phagocytosis by RPE is also supported by the
observed upregulation of c-mer proto-oncogene tyrosine kinase
MERTK, a critical regulator of RPE phagocytosis (f = 1.6) [23].
RPE lacking functional MERTK protein is defective in
phagocytosis of POS, whose accumulation leads to retinal
dystrophy [24].
The increased rate of rod OS synthesis is adopted by the
retina as a reaction to increased phagocytosis by RPE in order
to prevent total photoreceptor and vision loss. Zhang et al.
reported that, in culture, RPE cells fed by POS became
overloaded with calcium and accumulated lipofuscin [25].
Excessive calcium inflow may lead to impairment of function
and cell death [26]. Intracellular calcium has been linked to
ageing in brain cells, which is also accompanied by lipofuscin
accumulation [27,28]. We posit that increased RPE phagocytic
activity induced by HIV infection leads to calcium accumulation
and premature aging of the RPE layer via functional alterations
in the absence of thinning or other gross morphological
changes. We note that of the 39 RPE-specific genes identified
in a recent screening study [29], 12 were found significantly
regulated (FDR < 0.1), and all with the exception of RLBP1 are
downregulated (Figure S2). Monocarboxylate transporter 3
SLC16A3, whose decline correlates with advancing
degeneration of RPE in AMD [30], is downregulated (f = -1.4).
Likewise, 7-dehydrocholesterol reductase DHCR7, whose
inhibition in an animal model leads to RPE degeneration [31] is
downregulated (f = -1.3).
Cone-specific transcripts were moderately yet
systematically downregulated in HIV positive retinae
The posterior pole samples in this study were taken from a
region 3-4 mm from the fovea and contained an estimated
5-6% of cones, 94-95% of rods. Partial cone loss would not
therefore result in gross morphological changes but rather
manifest as a downregulation of cone-specific transcripts,
Figure 2.  Example of the CWS microperimetric abnormality demonstrating long term-damage.  Left Panel: Microperimetry
examination overlaid on color fundus photograph, at the area of the previous cotton wool spot. An intraretinal hemorrhage is present
superotemporal to the macula and a CWS is inferior to the optic nerve.
Middle Panel: Enlarged image of microperimetry overlay showing sensitivity values in dB over the area of CWS shows decreased
sensitivity (lower numbers in violet) over the area of previous cotton wool spot demonstrating long-term damage.
Right Panel: Color photograph of the retina of the same eye with a dot hemorrhage superotemporal to the macula and fading cotton
wool spot.
doi: 10.1371/journal.pone.0074712.g002
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Figure 3.  Heatmap of gene expression changes between
posterior pole retinal punches of HIV-positive (10 samples
on the right) and HIV-negative donor eyes (six samples on
the left).  Red and blue boxes indicate relative over- and
under-expression with respect to a mean level between the two
groups. Only genes with regularized t-statistic > 1 have been
included. Symbols in blue indicate genes discussed in text. The
samples are ordered by the donors’ time of death from left to
right in each group.
doi: 10.1371/journal.pone.0074712.g003
including opsins. This scenario is consistent with our findings:
cone-specific genes were moderately yet systematically
downregulated: Most notably, opsins OPN1SW (f = -1.4) and
OPN1LW (f = -1.4, FDR = 0.07), cone-specific PDE6 (subunits
PDE6C, f = -1.3, and PDE6H, f = -1.4, FDR = 0.15), and GRK7
(f = -1.2, FDR = 0.13), an enzyme with high specificity to cone
opsins (Figures 2 and 3).
The exact nature in which the ageing RPE affects rods and
cones differentially remains to be elucidated, but it is certainly
logical from an evolutionary viewpoint since color vision
evolved as a modification of and augmentation to an already
present monochromatic vision (in Arthropoda) [32], thus one
would expect rods to survive adverse conditions better than
cones. Selective cone death has been observed in genetic
retinopathies induced by genetic manipulation of RPE layer
[33] but also the ganglion cell layer [34]. Aside from obvious
morphological differences, there has to be a fundamental
molecular-level difference between rods and cones that
renders cones more susceptible to cell death. One likely
possibility is the different manner in which rods and cones
manage calcium signaling and homeostasis [35]. Genes
involved in rod calcium signaling and homeostasis, recoverin
RCVRN (f = 2.3) and Na-Ca+K exchanger SLC24A1 (f = 4.0)
were significantly upregulated. Retinal cone Na-Ca+K
exchanger SLC24A2 is unchanged. The Intracellular Calcium
Signaling pathway as a whole was significantly altered in HIV
retinae (adjusted p-value = 0.001) (Figure S3).
Comparison of tissue with an active CWS with lesion-
free retina
In order to compare tissue with an active CWS with lesion-
free retina, we compared 4 CWS samples with 4 HIV-positive
but otherwise ophthalmologically normal controls. 17 genes
were called differentially expressed at FDR level of 0.1.
Amongst the relevant biological processes, inflammatory
response (adjusted p-value 10-9) was prominent. However, pro-
inflammatory microglia-stimulating signals are downregulated
in CWS: allograft inflammatory factor 1 AIF1 (f = -1.8), S100
calcium binding proteins A8 and A9 (f = -2.4 and -2.7) (Figure
S4).
Comparison of tissue with IRH to lesion-free retinae
In order to compare tissues with IRH to lesion-free retinae,
we compared 6 samples with IRH to 6 samples of control HIV-
positive retinae. Four genes were differentially regulated at the
FDR level of 0.1. Thrombospondin 4 (THBS4), a modulator of
endothelial cell proliferation expressed by vascular cells is
upregulated (f = 1.6), which suggests rebuilding of the vascular
system at the site of injury. As in the case with CWS, it appears
that IRH lesions do not cause any additional modification to the
outer retina (Figure S5).
Examination of the influence of diurnal rhythm
There is one other possible explanation for the reported
molecular differences between HIV-negative and HIV-positive
retinae: It is conceivable that the retinal samples were
harvested in such a manner that the majority of the HIV-
negative samples originated from a different time of day (TOD)
Visual Decline in Non-Infectious HIV Retinopathy
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than most of the HIV-positive samples. This would confound
the analysis and the detected differences could primarily be
due to diurnal rhythm rather than HIV status. In order to verify
our microarray results and to investigate a potential role of
diurnal regulation on some of the transcripts, we performed
qPCR measurements of abundance of three transcripts, RHO,
OPN1SW and CRYBB2, for 15 HIV-positive retinae and 9 HIV-
negative controls. Figure 5 is a plot of transcript abundance
(relative to a reference gene, GAPDH) as a function of TOD.
The observed fold inductions are in a quantitative agreement
with microarray results. No obvious diurnal rhythm was
observed with any of these transcripts.
Our study is the first to show significant outer retinal
dysfunction in HIV-positive retinae. There has been much
evidence to date that inner retinal damage exists in HIV-
positive patients and that this affects structure and function but
these effects are mild to moderate in severity. It is known that
inner retinal disease can affect the outer retina in eyes with
inner retinal damage due to optic neuropathy [36]. It has also
been demonstrated that there is inner retinal disease in
patients with advanced outer retinal degeneration [37-39]. In
animal models of outer retinal dystrophy, as the outer retinal
degeneration progresses there is inner retinal disorganization
as well [40,41]. For these reasons we cannot state definitively
whether the distinct photoreceptor dysregulation we have
Figure 4.  Interaction network of genes involved in visual perception using MetaCore™ knowledge base [48].  The color
reflects direction and size of regulation in HIV-positive retinae compared to HIV-negative controls. A link signifies interaction, a bullet
is binding of protein products, an arrow means regulation of transcription or activation, and a hammer means inhibition or
deactivation.
doi: 10.1371/journal.pone.0074712.g004
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documented is independent of the known inner retinal damage
in HIV or whether the photoreceptor problems we outline in this
study contribute to the inner retinal damage.
Conclusions
In summary the systems wide studies reported here indicate
dysfunction retinal pathways unique to the phototransduction
process, i.e. rods and cones. This is the first report of a
previously unrecognized source of vision loss, not accounted
for by inner retinal disease (CWS, superficial retinal
hemorrhages and capillary drop out). This photoreceptor
damage/dysfunction is not associated with thinning or loss of
outer retinal layers as evidenced by spectral domain optical
coherence tomography (SD-OCT). Additionally we uncovered
modulation of inflammatory response in areas affected by
active CWS and changes in several vascular marker pathways
in areas with hemorrhages. This suggests that the CWS do
affect the inner retina but not the outer retina, but both retinal
layers are damaged in HIV infection.
Materials and Methods
Ethics Statement
The study was approved by the University of California San
Diego Institutional Review Board (http://www.sandiego.edu/irb),
and informed consent was taken from all study patients. Study
Figure 5.  Abundance of transcript measured by qPCR (relative to a reference gene GAPDH) in retinae of HIV-negative
and HIV-positive donors as function of time of death.  
doi: 10.1371/journal.pone.0074712.g005
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participants provided written informed consent to participate in
this study. The consent procedure was approved by the UCSD
Institutional Review Board ethics committee. Both the HIV-
positive patients and non-HIV age-matched healthy participants
come from a UCSD Institutional Review Board-approved,
National Institutes of Health-sponsored longitudinal study of
HIV disease at the University of California, San Diego (UCSD).
The research followed the tenets of the Declaration of Helsinki.
Structural evaluation in vivo of the retina after
ophthalmoscopic resolution of cotton wool spots
We performed a retrospective study of HIV patients who
were determined by clinical examination and fundus
photographs to have had retinal cotton wool spots (CWS) at
least 2 years prior to the initiation of the study. The clinically
active CWS disappear within 4 to 12 weeks leaving a localized
area of ischemic atrophy in pathology reports. All CWS were
confirmed by examination of stereo color transparency slides
taken with a color fundus camera (Canon USA, Lake Success,
NY or Topcon Incorporated, Paramus, New Jersey) and
recorded on ASA 100 35 mm film. Patients were imaged with a
simultaneous scanning laser ophthalmoscopy (SLO)/ Spectral
OCT (optical coherence tomography) device using red free and
infrared SLO imaging to portray fundus landmarks including
vessels (Heidelberg Spectralis OCT, Heidelberg Engineering,
Vista, CA). The serial scans were co-localized to the area of
the initial retinal cotton wool spot using the overlay software on
the OCT. The color fundus photograph and the SLO image
were registered and superimposed on each other using
commercial imaging software (Adobe Photoshop). The scan
line and point along that line closest to the center of the
ophthalmoscopically visible cotton wool spot was the one
chosen for the analysis and quantification of retinal layer
thickness (Figure 1).
Each CWS lesion had a control area taken from the same
eye. That area was chosen from the adjacent retina in an area
free of vessels within 1-2 disc diameters from the cotton wool
spot and approximately along the same nerve fiber layer arc.
Measurements of each retinal layer were done in microns by
two observers who were kept masked to whether the lesion
was a control or a resolved CWS. Each retinal layer was
measured in microns and then the data recorded for statistical
analysis. The thickness of each of the layers of retina at the
cotton wool spot was compared to its corresponding layers at
the nearest control area using the paired t-test. The SAS (SAS
Institute Inc., NC; version 9.2) multi-test procedure was used to
adjust the p-values from a family of hypothesis tests. The
Benjamini and Hochberg False discovery rate (FDR) control
method was used to control for multiple retinal layer
measurements per lesion.
Assessment of retinal function in areas of resolved
CWS by microperimetry
In order to further document the permanent anatomical
changes of long term resolved cotton wool spots just described
and to evaluate if these changes translate into a permanent
deficit in retinal sensitivity, we performed microperimetry
(OPKO instrumentation/OTI, Miami FL). During a
microperimetry test, a subjective measurement of the visual
function in a relatively small area of their retina (10° to 20°) is
obtained. A patient is shown visual stimuli at specific light
intensities, at specific locations on their retina. The patient uses
a hand held button/clicker to notify the system if they saw the
stimulus. That feedback (or lack thereof) determines the next
intensity to present that stimulus at. This process is repeated
for all of the stimuli in a predetermined pattern and
predetermined area. At the end of the test the operator is given
a fundus image with the stimulus pattern overlaid showing the
dimmest intensity at which each stimulus was seen by the
patient. The intensity level of the stimulus is displayed in dB.
The test was performed in the exact location of the previous
CWS and in normal adjacent retina in the same eye for control.
We used a custom designed pattern that allowed us to test
the retinal sensitivity in the area of the previous CWS and the
control area at the same time to avoid patient fatigue. It
consisted of 6 testing points in the area of the resolved CWS
and 4 adjoining points located 950 microns from the center of
the grid to be used as nearby controls. The size of the stimulus
used was 400 minarc2 (Goldmann III), with an area of 9156
square microns, 108 micron as retina spot size diameter with a
150msec duration which was sufficiently small to detect a
lesion and brief enough to avoid triggering eye movements.
The starting stimulus light attenuation was set at 10 dB.
The fixation target used was a red or green circle depending
on the color each patient preferred. To compensate for the
learning curve, a 2x2 grid test pattern was done in each eye
prior to the testing. The color fundus photograph containing the
original CWS and the microperimetry map image obtained
were superimposed on each other using commercial imaging
software (Adobe Photoshop).
The average of the microperimetry points within the CWS
was obtained as the lesion’s retinal sensitivity. The average of
the 4 adjoining dots was used as control. Any test spot
overlying a vessel was discarded as blood vessel reduced
retinal sensitivity by microperimetry. For statistical analysis, we
used a paired t-test, JUMP version 8.0 (SAS inc. Carey, North
Carolina)
Examination of color vision in HIV eyes
Patients.  For color vision function we compared
performance between HIV-positive and control subjects. Both
the HIV-positive patients and non-HIV age-matched healthy
participants for this assessment and the ones mentioned above
come from an Institutional Review Board-approved, National
Institutes of Health-sponsored longitudinal study of HIV disease
at the University of California, San Diego (UCSD). The
research followed the tenets of the Declaration of Helsinki.
The patients were divided into three groups. The high CD4
group consisted of HIV-positive patients with good immune
status whose CD4 counts were never valued at <100
(1.0x109/L). The low CD4 group were HIV-positive patients with
CD4 cell counts measured at <100 (1.0x109/L) at some period
of time in their medical history. None of the eyes had evidence
of retinopathy of other etiology. All HIV patients were on
combination antiretroviral therapy (cART) therapy prior to the
time of the examination and a substantial portion of these
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patients had a recovery in their CD4 counts. The HIV
individuals had no confounding ocular disease or eye surgery.
The normal group consisted of HIV- negative patients without
evidence of ocular damage.
Ophthalmologic evaluation.  All patients had a complete
ocular examination, including indirect ophthalmoscopy. The
exclusion criteria were corrected visual acuity worse than
20/40, spherical refraction beyond ± 5 diopters, cylindrical
correction greater than 3 diopters, unclear ocular media,
concurrent or healed CMV retinitis (a fellow eye without retinitis
was eligible), scotopic pupil size < 3mm, glaucoma or suspicion
of glaucoma, and diseases that can cause retinopathy, like
diabetes or uncontrolled hypertension.
Color vision hue discrimination testing.  We performed
Farmsworth-Munsell 100 hue discrimination test (FMTS,
Velbert, Germany) with computerized records. The second test
of each participant was analyzed to eliminate practice effect.
The raw error score (Windows-based PC scoring software
included) for each eye (f=85) represented the difference at
each position of the color circle of the expected cap and the
selected cap. This set of values was statistically compared
(Tukey HSD post-hoc pair-wise comparisons) among three
groups.
Tissue procurement
The autopsy eyes were procured from patients who had died
of clinically diagnosed AIDS. The eyes from both HIV-positive
and HIV-negative donors were obtained from either the San
Diego Eye Bank, the National Disease Research Institute or
the California NeuroAIDS Tissue Network including the
University of California San Diego (UCSD) autopsy service.
To prepare the total mRNA, eyes were opened at the limbus
post-enucleation (< 24 hrs post mortem), immediately placed in
50 mL of RNAlater (Ambion Inc., Austin, TX), and transported
on ice to our laboratory at the Shiley Eye Center, University of
California at San Diego (La Jolla, CA). In order to assure
prompt delivery of unfixed and fresh ocular material, a diener
was paid to enucleate the eyes, properly immerse them in
RNAlater, and then deliver them to the laboratory, where they
were placed at 4°C until dissection (up to 7 days). All work was
conducted employing Biosafety Level-II standards and
practices.
Dissection
Upon arrival to our lab, received eyes were recorded on a
data record with available patient information. Each eye was
identified, accessioned, and measured. At gross examination,
the limbal incision was enlarged, and the cornea and lens
removed, allowing dissection of lesions under a dissecting
microscope. After the remaining anterior segments (vitreous
humor) and excess RNAlater were partially removed, the eye
was examined. Gross pathological findings were recorded both
by photograph and on an autopsy data sheet. The remaining
vitreous was then gently and completely removed, and 4 radial
peripheral retinal incisions were made, while avoiding the
macula and major blood vessels, in order to lay the eyecup flat.
Separate, PCR clean, 2 mm trephines were used to punch
individual retina in areas of posterior pole with visible cotton
wool spots (CWS) or intraretinal hemorrhages (IH). If absent
the punches were taken from the retina in the posterior pole.
Six control punches from the peripheral retina were also taken
from each eye. The position of each biopsy was recorded on
the autopsy data sheet. Each punch was placed into a
separate pre-labeled vial containing 1.0 mL TRIzol reagent
(Invitrogen Life Technologies, Carlsbad, CA), snap frozen
(-80°C) and stored until processing and individual analysis.
Eyes containing CMV retinitis or retinitis lesions were excluded
from this study.
Isolation of total RNA for microarray studies
Retinal biopsies were placed directly in 1 mL TRIzol reagent
prior to nucleic acid extraction. The TRIzol protocol was
followed exactly as recommended by the manufacturer
(Invitrogen, Carlsbad, CA). Briefly, the biopsies were needle-
sheared, total RNA precipitated, purified and air-dried. The
pellet was then resuspended in a solution of water, DNase
buffer and DNase enzyme (Qiagen, Valencia, CA), and
incubated at room temperature 10 minutes to remove any
genomic DNA contamination. Total RNA was then purified on a
Qiagen RNeasy column according to manufacturer’s
instructions. Elution was carried out with RNase/DNase-free
water in two parts, combined and concentrated using a Savant
Integrated SpeedVac Vacuum System until the total volume
reached 15 µL. For RNA quantitation, the NanoDrop ND-1000
(NanoDrop Technologies, Inc. Wilmington, DE) was used. This
instrument measures the absorbance of RNA at 260 nm from 1
µL of sample. The samples were then transported to the UCSD
BIOGEM core for Illumina Beadarray processing.
DNA Microarray Experiments
Biotinylated cRNA was prepared using the Illumina RNA
Amplification Kit, Catalog #1L1791 (Ambion, Inc., Austin, TX)
according to the manufacturer’s directions starting with 250 ng
total RNA. For microarray analysis, the Illumina Human 6
Sentrix and HumanHT-12 v4 Expression BeadChip Kits were
used (Illumina, San Diego). Hybridization of labeled cRNA to
the BeadChip, and washing and scanning were performed
according to the Illumina BeadStation 500x manual. Essentially
the amplified, biotin-labeled human cRNA samples were
resuspended in a solution of Hyb E1 buffer (Illumina) and 25%
(v/v) formamide at a final concentration of 25 ng/µL. 1.5 µg of
each cRNA were hybridized. Hybridization was allowed to
proceed at 55°C, for 18 hours after which, the bead array
matrix was washed for 10 minutes with 1X High temperature
buffer (Illumina), followed by a subsequent 10 minute wash in
Wash E1BC buffer. The arrays were then washed with 100%
ethanol for 10 min to strip off any remaining adhesive on the
chip. A 2 minute E1BC wash was performed to remove residual
ethanol. The arrays were blocked for 5 minutes with 1% (w/v)
casein-PBS, (Pierce). The array signal was developed via 10
minute incubation with Streptavidin-Cy3 at a final concentration
of 1µg/mL solution of (GE Healthcare) in 1% casein-PBS
blocking solution. The Expression BeadChip was washed a
final time in Wash E1BC buffer for five minutes and
subsequently dried via centrifugation for 4 minutes at a setting
of 275 rcf.
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The arrays were scanned on the Illumina BeadArray Reader,
a confocal-type imaging system with 532 (cye3) nm laser
illuminations. Image analysis and data extraction was carried
out as in accordance with Illumina specifications. Preliminary
data analysis and QC was carried out using the GenomeStudio
software (Illumina). All array data has been deposited in the
EBI ArrayExpress Database. The ArrayExpress accessions are
E-MEXP-3758 and E-MEXP-3757
Analysis of microarray data
1) Normalization of microarray data.  Expression level
data from the Illumina Bead Studio software were normalized
using a multiple-loess algorithm [42]. Probes whose expression
level exceeds a threshold value in at least one sample are
called detected. The threshold value is found by inspection
from the distribution plots of (log) expression levels.
2) Sorting the probes according to
significance.  Detected probes are sorted according to their q-
value, which is the smallest false discovery rate (FDR) at which
the gene is called significant. FDR is the expected fraction of
false positive tests among significant tests [43]. We evaluate
FDR using Significance Analysis of Microarrays (SAM) and its
implementation in the official statistical package samr [44]. In
order to not be unduly impressed by accidentally small
variances, we set the percentile of standard deviation values
used for the exchangeability factor s0 in the test statistic to 75.
3) Statistical analysis of pathways and gene ontology
terms.  Each gene ontology term or a pathway is treated
simply as a set of genes. The probe list, sorted by q-value in
ascending order, is translated into Entrez gene ID’s and parsed
so that whenever several different probes represent the same
gene, only the highest-ranking probe is kept for further
analysis. The sorted list of genes is subjected to a non-
parametric variant of the Gene Set Enrichment Analysis
(GSEA) [45], in which the p-value of a gene set of size n is
defined as follows: Let us denote the k-th highest rank in gene
set as rk, and define pk as the probability that out of n randomly
chosen ranks (without replacement) the k-th highest is not
smaller than rk. The p-value of the gene set is defined as mink
[Pk] It is designed to detect overrepresented gene sets at the
top of the list. Unlike the Kolmogorov-Smirnov statistic used in
GSEA, it will not detect underrepresented or other,
pathologically distributed, gene sets. Finding the p-value of a
gene set of size n requires calculation of n rank-order values
pk, however, there is no need to adjust the p-values for multiple
testing as the rank-order tests are highly statistically
dependent. We do perform a Bonferroni adjustment of gene set
p-values for the number of gene sets tested, even though there
are often several gene sets with overlapping gene content (and
therefore are statistically dependent), which is partly due to the
design of the gene ontology database and partly because
genes tend to be involved in multiple processes. We report only
gene sets with adjusted p-values ≤ 0.01. Because of the
above-mentioned overlap of gene membership among gene
ontology terms, we believe that the significant terms should not
be reported as independent gene sets. Instead, we cluster the
significant gene sets using variation of information (VI) as the
distance metric [46], and present them graphically in this
context. VI between two gene sets is also called shared
information, and is a true metric. Gene sets that cluster
together generally share a number of member genes.
Heatmaps of expression levels were created using in-house
hierarchical clustering software. The colors qualitatively
correspond to fold changes with respect to a reference which is
calculated as the mid-point between compared groups.
Q-PCR Analysis
In order to investigate the influence of diurnal rhythm as an
explanation for the reported molecular differences between
HIV-negative and HIV-positive retinas, we employed Q-PCR.
We utilized the time of death (TOD) of our subjects as a proxy
for the time of day. The median TOD and standard deviation
among the HIV-negative group were 12: 30PM ± 6.8h; those of
the HIV-positive group 11: 00AM ± 7.1h, and the corresponding
ranges were 3:21AM―8:10PM and 0:15AM―7:30PM,
respectively. In order to verify the microarray results and better
investigate a potential role of diurnal regulation on some of the
key transcripts, we performed qPCR measurements of
abundance of three transcripts, RHO, OPN1SW and CRYBB2,
for 15 HIV-positive retinas and 9 HIV-negative controls. Data
were presented as a plot of transcript abundance (relative to a
reference gene, GAPDH) as a function of TOD. Q-PCR was
carried out as described previously [47]
Supporting Information
Figure S1.  Information clustering of significant
(Bonferroni adjusted p-value < 0.01) biological processes
in the comparison of HIV-negative and HIV-positive
donors. Numbers in parentheses are number of expressed
genes in the process and adjusted p-value. Hue of the red
color is proportional to (log) p-value; darker color means higher
significance.
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Figure S2.  Gene expression of RPE-specific genes in HIV-
negative (left panel) and HIV-positive donors.
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Figure S3.  Calcium signaling pathway. Gene expression in
HIV-negative (left panel) and HIV-positive donors.
(PDF)
Figure S4.  Gene expression in HIV-positive samples with
CWS (right panel) compared to ophthalmologically normal
HIV-positive samples.
(PDF)
Figure S5.  Gene expression in HIV-positive samples with
IRH (right panel) compared to ophthalmologically normal
HIV-positive samples.
(PDF)
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